Kim SY - Search Results

1

Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.

Park MK, You HJ, Lee HJ, Kang JH, Oh SH, Kim SY, Lee CH. Park MK, et al. Among authors: kim sy. Eur J Cancer. 2013 May;49(7):1692-705. doi: 10.1016/j.ejca.2012.11.036. Epub 2013 Jan 2. Eur J Cancer. 2013. PMID: 23290789

2

Transglutaminase 2 induces nitric oxide synthesis in BV-2 microglia.

Park KC, Chung KC, Kim YS, Lee J, Joh TH, Kim SY. Park KC, et al. Among authors: kim sy, kim ys. Biochem Biophys Res Commun. 2004 Oct 22;323(3):1055-62. doi: 10.1016/j.bbrc.2004.08.204. Biochem Biophys Res Commun. 2004. PMID: 15381106

3

Transglutaminase 2 in inflammation.

Kim SY. Kim SY. Front Biosci. 2006 Sep 1;11:3026-35. doi: 10.2741/2030. Front Biosci. 2006. PMID: 16720373 Review.

4

A Peptide with anti-transglutaminase activity decreases lipopolysaccharide-induced lung inflammation in mice.

Suh GY, Ham HS, Lee SH, Choi JC, Koh WJ, Kim SY, Lee J, Han J, Kim HP, Choi AM, Kwon OJ. Suh GY, et al. Among authors: kim sy, kim hp. Exp Lung Res. 2006 Jan-Feb;32(1-2):43-53. doi: 10.1080/01902140600691514. Exp Lung Res. 2006. PMID: 16809220 Free article.

5

Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation.

Kim DS, Park SS, Nam BH, Kim IH, Kim SY. Kim DS, et al. Among authors: kim ih, kim sy. Cancer Res. 2006 Nov 15;66(22):10936-43. doi: 10.1158/0008-5472.CAN-06-1521. Cancer Res. 2006. PMID: 17108131

6

Topical anti-inflammatory and antipruritic effects of Alpinia katsumadai extracts.

Choi JK, Kim KM, Kim DK, Yeom MH, Koh JY, Jung SJ, Kim HJ, Oh SH, Kim SY, Lee CH. Choi JK, et al. Among authors: kim km, kim hj, kim sy, kim dk. J Dermatol Sci. 2009 Jan;53(1):81-4. doi: 10.1016/j.jdermsci.2008.07.008. Epub 2008 Sep 3. J Dermatol Sci. 2009. PMID: 18771901 No abstract available.

7

Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition.

Kim DS, Park KS, Jeong KC, Lee BI, Lee CH, Kim SY. Kim DS, et al. Among authors: kim sy. Cancer Lett. 2009 Jan 18;273(2):243-9. doi: 10.1016/j.canlet.2008.08.015. Epub 2008 Sep 19. Cancer Lett. 2009. PMID: 18804908

8

Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells.

Park KS, Han BG, Lee KH, Kim DS, Kim JM, Jeon H, Kim HS, Suh SW, Lee EH, Kim SY, Lee BI. Park KS, et al. Among authors: kim ds, kim jm, kim sy, kim hs. Cancer Lett. 2009 Feb 18;274(2):201-7. doi: 10.1016/j.canlet.2008.09.007. Epub 2008 Oct 11. Cancer Lett. 2009. PMID: 18851895

9

GIPC mediates the generation of reactive oxygen species and the regulation of cancer cell proliferation by insulin-like growth factor-1/IGF-1R signaling.

Choi JS, Paek AR, Kim SY, You HJ. Choi JS, et al. Among authors: kim sy. Cancer Lett. 2010 Aug 28;294(2):254-63. doi: 10.1016/j.canlet.2010.02.007. Epub 2010 Mar 4. Cancer Lett. 2010. PMID: 20206441

10

Transglutaminase 2 gene ablation protects against renal ischemic injury by blocking constant NF-κB activation.

Kim DS, Kim B, Tahk H, Kim DH, Ahn ER, Choi C, Jeon Y, Park SY, Lee H, Oh SH, Kim SY. Kim DS, et al. Among authors: kim b, kim dh, kim sy. Biochem Biophys Res Commun. 2010 Dec 17;403(3-4):479-84. doi: 10.1016/j.bbrc.2010.11.063. Epub 2010 Nov 19. Biochem Biophys Res Commun. 2010. PMID: 21094133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,498 results

Search Page

Filters